Profound Medical (NASDAQ:PROF) Stock, Quote.Headers.trade-ideas

Profound Medical

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

microsoft shutter

News

Price Target

Markets

Analyst Ratings

Trading Ideas

DLTR

MSFT

PROF

RVMD

SBUX

SHOP

SPGI

TEAM

Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday

Earnings

Penny Stocks

Pre-Market Outlook

BLIN

CHRD

RETO

With U.S. stock futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday

Small Cap

COST

CTAS

SCVL

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

TD SYNNEX, Profound Medical And 3 Stocks To Watch Heading Into Tuesday

Profound Medical Corp

ProFrac Holding Corp. - Class A Common Stock

ProFrac Holding Corp

ProFrac Holding Corp Warrants (09/11/2023)

Professional Diversity Network, Inc. - Common Stock

Professional Diversity Network Inc

Professionally Managed Portfolios Congress Intermediate Bond ETF

Professionally Managed Portfolios Congress Large Cap Growth ETF

Professionally Managed Portfolios Congress SMid Growth ETF

Professionally Managed Portfolios Otter Creek Focus Strategy ETF

Proficient Auto Logistics, Inc. - Common Stock

Proficient Auto Logistics Inc

PROFILE SOLUTIONS INC by Profile Solutions, Inc.

Profile Solutions Inc

Profire Energy Inc

PROFIT PLANNERS MGMT NEW by Profit Planners Management, Inc.

Profit Planners Management Inc

PROFITABLE DEVELOPMENTS by Profitable Developments, Inc.

Profitable Developments Inc

In a report released today, Ben Haynor from Lake Street initiated coverage with a Buy rating on Profound Medical (PRN – Research Report) and a pric...

Profound Medical (PRN) Receives a Buy from Lake Street

Profound Medical GAAP EPS of $0.28 beats by $0.56, revenue of $1.46M misses by $0.93M

Profound Medical (TSE:PRN) has released an update. Profound Medical Corp. reported a 39% increase in Q2 2024 revenue, reaching $2.23 million, drive...

Profound Medical Sees Strong Revenue Growth in Q2

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Profound Medical</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/prof-stock-quote/"><strong>PROF</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Profound Medical reported earnings per share of -28 cents. This was above the analyst estimate for EPS of -29 cents.</li><li>The company reported revenue of $2.23 million.</li><li>This was 13.78% worse than the analyst estimate for revenue of $2.59 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/prof-stock-earnings-profound-medical-for-q2-of-2024/">PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024

Profound Medical Corporation (PROF) Q2 2024 Earnings Call Transcript

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Profound Medical (PRN – Research Report), with a price target...

Profound Medical (PRN) Receives a Buy from Stifel Nicolaus

Lake Street analyst Ben Haynor maintained a Buy rating on Profound Medical (PRN – Research Report) today and set a price target of $16.50. The comp...

Profound Medical (TSE:PRN) has released an update. Profound Medical Corp., specializing in incision-free therapies for diseased tissue, will be att...

Profound Medical to Attend Growth Ideas Conference

Profound Medical (TSE:PRN) has released an update. Profound Medical Corp recently held their ‘PRO-Talk Live!' event, attracting physicians to discu...

Profound Medical Hosts Insightful Prostate Treatment Event

In a report released today, Ben Haynor from Lake Street assigned a Buy rating to Profound Medical (PRN – Research Report), with a price target of $...

Lake Street Issues a Buy Rating on Profound Medical (PRN)

Press Releases

Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Profound Medical

Profound Medical (PROF) Forecast

Profound Medical (NASDAQ:PROF) Stock, Quote.Headers.trade-ideas